🇺🇸 FDA

Intelligence · Drug directory

FDA-Approved Drugs Directory

US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

Quick answer

FDA-approved drugs: NovaPharmaNews tracks 2,719 pharmaceutical drugs in this segment. US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

2,719 drugs · FDA approved · by data quality · Page 31 of 114

  1. ranitidine hydrochloride

    RANITIDINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  2. ranolazine

    RANEXA (PREVIOUSLY LATIXA) Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: approved

    C01EB18

  3. rasagiline mesylate

    RASAGILINE MESYLATE Teva Pharma GmbH

    ORAL FDA: approved

  4. rauwolfia serpentina root

    RAUWOLFIA SERPENTINA Teva Pharma GmbH

    ORAL FDA: approved

  5. relacorilant

    LIFYORLI (COPACKAGED) CORCEPT THERAPEUTICS INC

    ORAL FDA: approved

  6. repaglinide

    REPAGLINIDE SUN Teva Pharma GmbH

    ORAL FDA: approved · EMA: approved

    A10BX02

  7. reserpine

    RESERPINE BICYCLE THERAPEUTICS

    INJECTION FDA: approved

  8. reslizumab

    CINQAERO Teva Pharma GmbH

    INJECTION FDA: approved · EMA: approved

    R03DX08

  9. resmetirom

    REZDIFFRA Madrigal Pharmaceuticals EU Limited

    ORAL FDA: approved · EMA: approved

    A05

  10. retapamulin

    ALTARGO Almirall, S.A.

    TOPICAL FDA: approved · EMA: withdrawn

    D06AX13

  11. revumenib citrate

    REVUFORJ Syndax Pharmaceuticals

    ORAL FDA: approved

  12. ribavirin

    RIBAVIRIN BIOPARTNERS Teva Pharma GmbH

    ORAL FDA: approved · EMA: withdrawn · PMDA: approved

    J05AP01

  13. rifampin

    RIFADIN Teva Pharma GmbH

    INJECTION FDA: approved · NMPA: clinical trials

  14. rilonacept

    RILONACEPT FGK REPRESENTATIVE SERVICE GMBH Regeneron UK Limited

    SINGLE-USE FDA: approved · EMA: application withdrawn

    L04AC04

  15. riluzole

    PHARMACOR RILUZOLE Sanofi-aventis Healthcare Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    N07XX02

  16. riociguat

    ADEMPAS Bayer Australia Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    C02KX05

  17. risedronate sodium

    RISEDRONATE SODIUM Teva Pharma GmbH

    ORAL FDA: approved

  18. risperidone

    APO-RISPERIDONE Servier Laboratories (Aust.) Pty.

    INTRAMUSCULAR FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    N05AX08

  19. ritonavir

    NORVIR AbbVie

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    J05AE03

  20. rivaroxaban

    APO-RIVAROXABAN Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    B01AF01

  21. rivastigmine

    EXELON Novartis Pharmaceuticals

    TRANSDERMAL FDA: approved · EMA: approved · TGA: approved

    N06DA03

  22. rizatriptan benzoate

    RIZATRIPTAN BENZOATE Teva Pharma GmbH

    ORAL FDA: approved

  23. rocuronium bromide

    ROCURONIUM BROMIDE Teva Pharma GmbH

    INJECTION FDA: approved

  24. roflumilast

    DAXAS Arcutis Biotherapeutics

    TOPICAL FDA: approved · EMA: approved

    R03DX07

Frequently asked questions

How many fda approved drugs are listed?

2,719 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.